In the fiercely competitive inflammatory bowel disease (IBD) market, Eli Lilly is making the case for its antibody Omvoh as a ...

U.S.-based generic drugmaker Par Health has issued a voluntary recall of 22 lots of the direct thrombin inhibitor argatroban ...

As the momentum continues to pick up at NorthStar Medical Technologies, the radioisotope producer is strengthening ties in ...

Meridian Medical Technologies—the global health security subsidiary of CDMO Kindeva—just secured a major contract, worth up to a potential $226 million, with the DoD's Defense Logistics Agency to ...

Following a bumpy regulatory road that involved a refusal-to-file, ImmunityBio has won FDA approval to expand Anktiva into ...

Hot off a pair of key FDA green lights this summer, rare disease specialist Ultragenyx has wasted little time cashing in a ...

Compass Pathways has partnered with mental health organizations on the first-ever awareness day for treatment-resistant ...

Expanding its presence in dermatology, Cetaphil maker Galderma has agreed to acquire professional skincare shop Zo Skin ...

Sanofi has avoided a European Union fine after antitrust regulators accepted its commitments to address the alleged ...

Martin Shkreli is back in the Federal Trade Commission’s spotlight, this time for allegedly violating his l | The FTC alleges ...

With a yearslong patent dispute between the two drugmakers finally put to bed—complete with a hefty settlement payout—United ...

Seizing that momentum these past two weeks were Prolific Machines—aiming optogenetics at current biomanufacturing ...